[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Antiparasitic Drugs Market Size, Trends, Analysis, and Outlook by Drug Type (Anthelmintics, Antiprotozoals, Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030

March 2024 | 190 pages | ID: A17657A236EDEN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Antiparasitic Drugs market size is poised to register 5.57% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Antiparasitic Drugs market across by Drug Type (Anthelmintics, Antiprotozoals, Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others).

The antiparasitic drugs market in 2024 and beyond is influenced by several significant trends and driving forces. One key trend is the persistence of parasitic infections as a global health burden, particularly in tropical and subtropical regions where socioeconomic factors contribute to disease transmission. As efforts to control parasitic diseases intensify, the demand for effective antiparasitic therapies grows, driving market expansion. Moreover, advancements in drug development and formulation technologies enable the introduction of novel antiparasitic agents with improved efficacy, safety, and patient compliance, addressing unmet medical needs. Additionally, strategic collaborations between pharmaceutical companies, governments, and non-profit organizations facilitate drug access and affordability, enhancing treatment outcomes and reducing disease burden. Regulatory initiatives to support antiparasitic drug development and ensure product quality further shape market dynamics, fostering innovation and market accessibility.

Antiparasitic Drugs Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Antiparasitic Drugs market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Antiparasitic Drugs survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Antiparasitic Drugs industry.

Key market trends defining the global Antiparasitic Drugs demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Antiparasitic Drugs Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Antiparasitic Drugs industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Antiparasitic Drugs companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Antiparasitic Drugs industry

Leading Antiparasitic Drugs companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Antiparasitic Drugs companies.

Antiparasitic Drugs Market Study- Strategic Analysis Review

The Antiparasitic Drugs market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Antiparasitic Drugs Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Antiparasitic Drugs industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Antiparasitic Drugs Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Antiparasitic Drugs Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Antiparasitic Drugs market segments. Similarly, Strong end-user demand is encouraging Canadian Antiparasitic Drugs companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Antiparasitic Drugs market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Antiparasitic Drugs Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Antiparasitic Drugs industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Antiparasitic Drugs market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Antiparasitic Drugs Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Antiparasitic Drugs in Asia Pacific. In particular, China, India, and South East Asian Antiparasitic Drugs markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Antiparasitic Drugs Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Antiparasitic Drugs Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Antiparasitic Drugs market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Antiparasitic Drugs.

Antiparasitic Drugs Market Company Profiles

The global Antiparasitic Drugs market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Bayer, Cipla Ltd., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Ipca Laboratories Ltd., Mankind Pharma, Merck KGaA, Novartis AG, Sanofi, Zydus Group

Recent Antiparasitic Drugs Market Developments

The global Antiparasitic Drugs market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Antiparasitic Drugs Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Drug Type

Anthelmintics

Antiprotozoals

Others

By Route of Administration

Oral

Injectable

Topical

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

Bayer

Cipla Ltd.

F. Hoffmann-La Roche Ltd

GlaxoSmithKline plc

Ipca Laboratories Ltd.

Mankind Pharma

Merck KGaA

Novartis AG

Sanofi

Zydus Group

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Antiparasitic Drugs Market Overview and Key Findings, 2024
1.2 Antiparasitic Drugs Market Size and Growth Outlook, 2021- 2030
1.3 Antiparasitic Drugs Market Growth Opportunities to 2030
1.4 Key Antiparasitic Drugs Market Trends and Challenges
  1.4.1 Antiparasitic Drugs Market Drivers and Trends
  1.4.2 Antiparasitic Drugs Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Antiparasitic Drugs Companies

2. ANTIPARASITIC DRUGS MARKET SIZE OUTLOOK TO 2030

2.1 Antiparasitic Drugs Market Size Outlook, USD Million, 2021- 2030
2.2 Antiparasitic Drugs Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. ANTIPARASITIC DRUGS MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. ANTIPARASITIC DRUGS MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Drug Type
Anthelmintics
Antiprotozoals
Others
By Route of Administration
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Antiparasitic Drugs Market, 2025
5.2 Asia Pacific Antiparasitic Drugs Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Antiparasitic Drugs Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Antiparasitic Drugs Market, 2025
5.5 Europe Antiparasitic Drugs Market Size Outlook by Type, 2021- 2030
5.6 Europe Antiparasitic Drugs Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Antiparasitic Drugs Market, 2025
5.8 North America Antiparasitic Drugs Market Size Outlook by Type, 2021- 2030
5.9 North America Antiparasitic Drugs Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Antiparasitic Drugs Market, 2025
5.11 South America Pacific Antiparasitic Drugs Market Size Outlook by Type, 2021- 2030
5.12 South America Antiparasitic Drugs Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Antiparasitic Drugs Market, 2025
5.14 Middle East Africa Antiparasitic Drugs Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Antiparasitic Drugs Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Antiparasitic Drugs Market Size Outlook and Revenue Growth Forecasts
6.2 US Antiparasitic Drugs Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Antiparasitic Drugs Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Antiparasitic Drugs Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Antiparasitic Drugs Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Antiparasitic Drugs Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Antiparasitic Drugs Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Antiparasitic Drugs Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Antiparasitic Drugs Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Antiparasitic Drugs Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Antiparasitic Drugs Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Antiparasitic Drugs Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Antiparasitic Drugs Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Antiparasitic Drugs Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Antiparasitic Drugs Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Antiparasitic Drugs Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Antiparasitic Drugs Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Antiparasitic Drugs Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Antiparasitic Drugs Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Antiparasitic Drugs Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Antiparasitic Drugs Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Antiparasitic Drugs Industry Drivers and Opportunities

7. ANTIPARASITIC DRUGS MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. ANTIPARASITIC DRUGS COMPANY PROFILES

8.1 Profiles of Leading Antiparasitic Drugs Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Bayer
Cipla Ltd.
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Ipca Laboratories Ltd.
Mankind Pharma
Merck KGaA
Novartis AG
Sanofi
Zydus Group

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications